Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 17, 2016

View Archived Issues

Clinical safety and pharmacodynamics of VLX-103 in cirrhotic patients with early-stage HCC

Promising clinical data for TS-23 supports future development in thrombotic vascular diseases

FDA grants orphan drug designation to Genexine's GX-H9

Imara doses first volunteer in IMR-687 phase I trial

ALD-1910 induces photophobia in WT CT1 mice

Sorrento's TNK Therapeutics signs binding term sheet to acquire Virttu Biologics

EMA grants PRIME to SAGE-547 for postpartum depression

Genexine signs agreement with Merck & Co.

Cuvitru now available in U.S. for patients with primary immunodeficiency

LLS commits USD 40.3 million to fund new research into hematologic cancers

AstraZeneca announces completion of MEDI-2070 outlicensing agreement with Allergan

GTx to advance enobosarm phase II trial to final stage

Grunenthal acquires Thar Pharmaceutical

Tianjin Institute of Pharmaceutical Research patents URAT1 inhibitors

FDA grants fast track designation to crenolanib for GIST

Concert Pharmaceuticals discloses OTX-015 analogues

Daewoong Pharmaceutical describes ATPase inhibitors and/or 5-HT2A and/or M1 and/or M2 antagonists

Agilis Biotherapeutics treats first patient in phase IIb study of AGIL-AADC

Novartis reports promising topline results from STRIVE trial of AMG-334 in episodic migraine

Japanese researchers develop antimalarial agents

Chinese scientists present FXR agonists

Gilead reports topline results from phase III trials of momelotinib in myelofibrosis

Antidepressant effects of SUVN-1507035 in animal models of psychosis

CTC biomarker identifies CRPC patients likely to respond to PARP inhibitor treatment

Sofosbuvir, ledipasvir and ribavirin give high cure rates in drug users with hepatitis C

DSMB recommends continuation of phase III study of PXT-003 for CMT1A

Pfizer initiates phase I trial of PF-06747143 in AML

CD40L-encoding adenovirus enhances dendritic cell therapy for cancer

EMA grants positive opinion for teriparatide biosimilar

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Gene therapies aim for the big goal of edits in vivo
BioWorld Science
The field of gene therapy is experiencing major advances driven by precise editing technologies, such as base and prime editing, and by the design of increasingly...